![](https://krogerus-website.transforms.svdcdn.com/production/Stairs-4.jpg?w=1800&h=696&q=100&fm=jpg&fit=crop&dm=1718191309&s=52d6cd3b853b4e438acce307a016a902 1800w, https://krogerus-website.transforms.svdcdn.com/production/Stairs-4.jpg?w=768&h=297&q=100&fm=jpg&fit=crop&dm=1718191309&s=3f50fb9a0171e8c005ad5f8b728492e9 768w)
Krogerus advises Aiforia on its IPO and listing on Nasdaq First North Growth Market Finland
Krogerus advised Aiforia on its initial public offering and listing on Nasdaq First North Growth Market Finland.
Aiforia's market capitalisation based on the subscription price in the IPO is approximately EUR 130 million. Aiforia receives gross proceeds of approximately EUR 30 million from the IPO assuming that the over-allotment option is exercised in full.
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities.
The Krogerus team, led by Partner Tom Fagernäs, included Senior Associate Joel Kanervo and Associates Samuli Torpisto, Markus Laine, Olli Silvennoinen and Kalle Lipsanen.